IQVIA HOLDINGS INC.

LISTEDNYSE

SYMBOLIQV

SIC8731

STATE OF INC.DE

FISCAL YEAR ENDSDecember 31

CIK1478242

SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH · LARGE ACCELERATED FILER · 10 FISCAL YEARS OF SEC XBRL DATA, 2016–2025

Fiscal years labelled by the calendar year in which they end. Bars in $ billions; per-share figures as reported.

CAPITALIZATION 12/31/25

($ millions)	Amount	%
Total debt	15,724	70.7
Stockholders' equity	6,503	29.3
Total capitalization	22,227	100.0

166,900,000 shares outstanding at 30 April 2026 (cover page of the 10-Q filed 5 May 2026).

LONG-TERM DEBT 12/31/25

($ millions)	Amount
Long-term debt, noncurrent	13,884
Current maturities	1,840

CAPITAL STOCK 12/31/25

Common shares authorized	400,000,000
Common shares issued	259,100,000
Treasury shares	89,500,000
Par or stated value per share ($)	0.01
Outstanding at 4/30/26	166,900,000

DIVIDENDS DECLARED/PAID

Fiscal year	Per share $	Payout %
2025	–	–
2024	–	–
2023	–	–
2022	–	–
2021	–	–

HISTORY AND BUSINESS

HISTORY: Incorporated in Delaware. Formerly known as Quintiles IMS Holdings, Inc. (to 3 November 2017); Quintiles Transnational Holdings Inc. (to 22 September 2016).

BUSINESS: Classified by the SEC under Standard Industrial Classification 8731, Services-Commercial Physical & Biological Research. Large accelerated filer. Principal executive office: 2400 Ellis Road, Durham, NC 27703. Fiscal year ends December 31. For a description of the business, see Item 1 of the latest 10-K.

CONSOLIDATED INCOME ACCOUNT, YEARS ENDED

($ millions)	12/31/25	12/31/24	12/31/23
Revenues	16,310	15,405	14,984
Selling, general and administrative	1,999	1,992	2,053
Depreciation and amortization	1,144	1,114	1,125
Operating income	2,182	2,202	1,977
Interest expense	729	670	672
Income before income taxes	1,591	1,669	1,459
Income taxes	252	301	101
Net income	1,360	1,373	1,358
Earned per share, diluted ($)	7.84	7.49	7.29
Dividends per share ($)	–	–	–

CONSOLIDATED BALANCE SHEET

($ millions)	12/31/25	12/31/24
Cash and equivalents	1,980	1,702
Receivables, net	3,400	3,204
Total current assets	6,249	5,829
Property, plant and equipment, net	533	535
Goodwill	16,616	14,710
Total assets	29,944	26,899
Total current liabilities	8,338	6,957
Long-term debt	13,884	12,838
Total liabilities	23,314	20,832
Stockholders' equity	6,503	6,067
Total liabilities and equity	29,944	26,899

TEN-YEAR STATISTICS: FISCAL YEARS ($ millions except per share)

Fiscal year ended	Revenues	Oper. income	Net income	Net margin %	EPS diluted $	Div. per share $	Oper. cash flow	Capital expend.	Free cash flow	Total assets	Total liabilities	Total debt	Stockholders' equity	ROE %	Debt / equity
12/31/25	16,310	2,182	1,360	8.3	7.84	–	2,654	603	2,051	29,944	23,314	15,724	6,503	20.9	2.42
12/31/24	15,405	2,202	1,373	8.9	7.49	–	2,716	602	2,114	26,899	20,832	13,983	6,067	22.6	2.30
12/31/23	14,984	1,977	1,358	9.1	7.29	–	2,149	649	1,500	26,681	20,569	13,673	6,112	22.2	2.24
12/31/22	14,410	1,799	1,091	7.6	5.72	–	2,260	674	1,586	25,337	19,572	12,747	5,765	18.9	2.21
12/31/21	13,874	1,393	966	7.0	4.95	–	2,942	640	2,302	24,689	18,647	12,125	6,042	16.0	2.01
12/31/20	11,359	731	279	2.5	1.43	–	1,959	616	1,343	24,564	18,284	12,533	6,001	4.6	2.09
12/31/19	11,088	777	191	1.7	0.96	–	1,417	582	835	23,251	16,988	11,645	6,003	3.2	1.94
12/31/18	10,412	741	259	2.5	1.24	–	1,254	459	795	22,549	15,595	11,007	6,714	3.9	1.64
12/31/17	9,739	665	1,277	13.1	5.74	–	970	369	601	22,857	14,613	10,269	7,995	16.0	1.28
12/31/16	6,878	576	72	1.0	0.47	–	860	164	696	21,208	12,348	7,219	8,633	0.8	0.84

Net margin = net income ÷ revenues; ROE = net income ÷ year-end stockholders’ equity; total debt = long-term debt including current maturities plus short-term borrowings/commercial paper, as tagged in XBRL; free cash flow = operating cash flow − purchases of property, plant and equipment; d = derived as total assets − total equity where the filing does not tag total liabilities; – = not reported in XBRL for that year.

REGISTRANT:

IQVIA HOLDINGS INC.
CIK 1478242 · EIN 27-1341991

PRINCIPAL OFFICE:

2400 Ellis Road, Durham, NC 27703
Tel.: 919-998-2000

INCORPORATED:

Delaware

INDUSTRY (SEC SIC CODE):

8731 · Services-Commercial Physical & Biological Research

FILER STATUS:

Large accelerated filer

LATEST ANNUAL REPORT:

10-K for period ended 12/31/25, filed 17 February 2026

FORMER NAMES:

Quintiles IMS Holdings, Inc.; Quintiles Transnational Holdings Inc.

RECENT FILINGS (ANNUAL REPORT REFERENCES BELOW):

9/23/26	8-K	period 9/23/26
9/9/26	8-K	period 9/9/26
7/28/26	10-Q	period 6/30/26
7/28/26	8-K	period 7/28/26
6/11/26	8-K	period 6/11/26
6/4/26	8-K	period 6/4/26
6/3/26	8-K	period 6/3/26
5/7/26	8-K	period 5/7/26

Sources: SEC XBRL company facts (all financial figures) · SEC submissions (registrant, address, SIC, filings) · annual reports: 10-K FY2025 (filed 2/17/26) · 10-K FY2024 (filed 2/13/25) · 10-K FY2023 (filed 2/15/24) · 10-K FY2022 (filed 2/15/23) · 10-K FY2021 (filed 2/16/22) · 10-K FY2020 (filed 2/12/21) · 10-K FY2019 (filed 2/18/20) · 10-K FY2018 (filed 2/19/19). Values are the latest figures filed for each fiscal year (restated where a later 10-K restated them). Ratios and free cash flow are Pathos calculations from those figures. Retrieved 31 October 2026.